Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07611786

Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia

Conditions: Congenital Adrenal Hyperplasia

Sex: All
Ages: 16 Years – N/A
Healthy volunteers: Yes
Enrollment: 40
Sponsor: University of Alabama at Birmingham

Location: University of Alabama at Birmingham Birmingham Alabama

Summary

The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on transition readiness, disease-specific self-management knowledge, emergency preparedness, continuity of endocrine care, and health-related quality of life as participants transition from pediatric to adult healthcare services.

Eligibility Criteria

Inclusion Criteria: YA Participants * Diagnosis of congenital adrenal hyperplasia (any subtype or severity) * Age ≥16 years * Active follow-up within the pediatric endocrinology clinic * English-speaking * Cognitively able to complete questionnaires with or without assistance * Anticipated ability to participate in CAH-T visits during the study period Caregiver Participants * Parent, guardian, or primary support person of an enrolled AYA participant Provider Participants * Pediatric endocrinologists, nurse practitioners, or transition-related clinical staff involved in CAH care for at least 6 months Exclusion Criteria: * Significant cognitive impairment precluding participation * Inability to complete study procedures * Inability to provide informed consent/assent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07611786). StuddyBuddy aggregates publicly available trial information.